1007583-26-7

Basic information

• Product Name: methyl 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutanoate
• Synonyms: methyl 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutanoate
• CAS NO: 1007583-26-7
• Molecular Weight: 409.227
• Mol File: 1007583-26-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutanoate(1007583-26-7)
• EPA Substance Registry System: methyl 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutanoate(1007583-26-7)

Safety Data

• Hazardous Substances Data: 1007583-26-7(Hazardous Substances Data)

Upstream product

• 99-73-0 para-bromophenacyl bromide 
• 1007583-54-1 methyl 2-amino-4,4,4-trifluorobutanoate hydrochloride 
• 65679-14-3 1-(4-bromophenyl)-2-thiocyanatoethanone 

Downstream Products

• 1007583-27-8 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-4,4,4-trifluorobutan-1-ol 

Relevant articles and documents

Oxazolidone derivatives as PR modulators

Compounds of the following structure are described: wherein R1, R2, R5, R6, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a variety of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.